NCT04106492 2025-11-14Phase 1/2a Study of SQ3370 in Patients With Advanced Solid TumorsShasqi, Inc.Phase 1/2 Terminated53 enrolled 23 charts
NCT05864144 2025-08-15A Study of SNS-101 (Anti VISTA) Monotherapy and in Combination With Cemiplimab in Patients With Advanced Solid TumorsSensei Biotherapeutics, Inc.Phase 1/2 Active not recruiting98 enrolled
NCT05949632 2025-08-03A Study of INCB099280 in Combination With Axitinib in Adults With Advanced Solid TumorsIncyte CorporationPhase 1/2 Terminated5 enrolled
NCT03476681 2025-04-24Study of NEO-201 in Solid Tumors Expansion CohortsPrecision Biologics, IncPhase 1/2 Recruiting121 enrolled
NCT04424641 2023-07-25A Study on the Safety of GEN1044 (DuoBody®-CD3x5T4) in Patients With Malignant Solid TumorsGenmabPhase 1/2 Terminated48 enrolled 20 charts
NCT05708950 2023-07-13A Clinical Trial of KVA12123 Treatment Alone and in Combination With Pembrolizumab In Advanced Solid Tumors (VISTA-101)Kineta Inc.Phase 1/2 Unknown314 enrolled
NCT03989115 2023-06-26Dose-Esc/Exp RMC4630 & Cobi in Relapsed/Refractory Solid Tumors & RMC4630& Osi in EGFR+ Locally Adv/Meta NSCLCRevolution Medicines, Inc.Phase 1/2 Completed113 enrolled 22 charts